new oral glp 1 agonist Danuglipron: An GLP-1R Competing with Peptide Injectables for Diabetes and Obesity GLP-1 Drug Savings: A Complete

GLP-1 medications can improve sleep quality and reduce sleep apnea symptoms through weight loss and direct effects on sleep patterns

Diabetol Metab Syndr 15(1):53 Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M et al (2024) Sarcopenia and sarcopenic obesity and mortality among older people

Feeling tired while on semaglutide GLP-1, a medication used for type 2 diabetes and obesity, can stem from multiple reasons

The combination of GLP-1 receptor agonists and DPP-4 inhibitors is not recommended, not due to safety issues, but since a clinically significant additional benefit is not expected (see below) (7072)

doi:10.1111/dom.13025 42